[ Centogene AG raises $27.99M in Series A funding ]
Centogene AG has raised $27.99 million in Series A funding.
Founded in 2006, Centogene AG is a worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio covering over 2800 genes, biochemical tests, biomarker and clinical whole exome sequencing and whole genome sequencing.
The proceeds of the financing will be used to accelerate the company’s further growth and expansion plans in the business segments of worldwide Genetic Testing, Pharmaceutical Collaborations and Big Data-Solutions.
|City||Rostock, Mecklenburg- Vorpommern|
|Founder / CEO||Joachim Schindler|
|TVM Capital Life Science|
|DPE Deutsche Private Equity|